Bellevue Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bellevue Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-144,957	Closed	-$6.87M	–	188
2021 Q4	$6.87M	Sell	144,957 -18,000	-11%	-$1.08M	0.07%	117
2021 Q3	$11.8M	Sell	162,957 -20,500	-11%	-$1.48M	0.12%	114
2021 Q2	$15.4M	Sell	183,457 -15,000	-8%	-$990K	0.15%	114
2021 Q1	$9.62M	Sell	198,457 -4,755	-2%	-$258K	0.1%	122
2020 Q4	$9.58M	Buy	203,212 +138,212	+213%	+$5.44M	0.11%	116
2020 Q3	$3.06M	Buy	+65,000	New	+$2.14M	0.04%	135

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bellevue Group's NBP Position: Q1 2022 in Review

Bellevue Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 144,957 shares — an estimated $6.87M sold.

Bellevue Group first reported a position in NBP in Q3 2020 and held it in 6 quarters. The position peaked at $15.4M in Q2 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

Bellevue Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Bellevue Group sold 144,957 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $6.87M.
Bellevue Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 6 quarters.
Bellevue Group's NovaBridge Biosciences American Depositary Shares position peaked at $15.4M in Q2 2021.
120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.